Entering text into the input field will update the search result below

Psychemedics Q3 revenues up 66%; net income up 240%; shares up 23%

Oct. 27, 2016 11:03 AM ETPsychemedics Corporation (PMD) StockPMDBy: Douglas W. House, SA News Editor
  • Psychemedics (PMD +22.6%) Q3 results ($M): Revenues: 11.8 (+66.2%); Net Income: 2.7 (+240.0%); EPS: 0.49 (+226.7%).
  • $0.15 dividend declared.
  • The company specializes in abused drug testing on hair instead of urine or blood. Traces of drugs are permanently embedded in the cortex of the hair in proportion to their use over time.

Recommended For You

More Trending News

About PMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PMD--
Psychemedics Corporation